Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:MDCO

Medicines (MDCO) Stock Price, News & Analysis

Medicines logo

About Medicines Stock (NASDAQ:MDCO)

Advanced Chart

Key Stats

Today's Range
$84.90
$84.90
50-Day Range
$84.90
$84.90
52-Week Range
$17.81
$84.98
Volume
N/A
Average Volume
9.55 million shs
Market Capitalization
$6.77 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive MDCO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medicines and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MDCO Stock News Headlines

TYK Medicines Announces Board Composition and Roles
Altucher: It Looks Like My Trump prediction is coming true
New Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Trump’s Great Gain” has officially begun. Altucher believes select cryptos could turn $900 into $108,000 over the next 12 months — and he’s laying out the full gameplan in a new presentation.tc pixel
TYK Medicines Reports Reduced Losses in H1 2025
Everest Medicines Announces 2025 Interim Results
See More Headlines

MDCO Stock Analysis - Frequently Asked Questions

The Medicines Company (NASDAQ:MDCO) released its earnings results on Wednesday, October, 30th. The company reported ($0.92) EPS for the quarter, missing the consensus estimate of ($0.80) by $0.12.

Based on aggregate information from My MarketBeat watchlists, some other companies that Medicines investors own include Bristol Myers Squibb (BMY), NVIDIA (NVDA), Gilead Sciences (GILD), Micron Technology (MU), AbbVie (ABBV), Alibaba Group (BABA) and Salesforce (CRM).

Company Calendar

Last Earnings
10/30/2019
Today
8/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
Pharmaceuticals
Current Symbol
NASDAQ:MDCO
CIK
1113481
Fax
N/A
Employees
62
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($2.91)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$123.16 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-25.70%

Debt

Debt-to-Equity Ratio
21.45
Current Ratio
0.77
Quick Ratio
0.77

Sales & Book Value

Annual Sales
$6.14 million
Price / Sales
1,102.36
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.30) per share
Price / Book
-283.00

Miscellaneous

Outstanding Shares
79,723,000
Free Float
N/A
Market Cap
$6.77 billion
Optionable
Optionable
Beta
1.10
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NASDAQ:MDCO) was last updated on 8/31/2025 by MarketBeat.com Staff
From Our Partners